No Data
Here's Why We're Not At All Concerned With Janux Therapeutics' (NASDAQ:JANX) Cash Burn Situation
We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow
JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $90
WEX, Lamb Weston, and More Stocks See Action From Activist Investors -- Barrons.com
Buy Rating for Janux Therapeutics: Promising Technology and Strong Financial Position Amid Competitive Pressure
Ra Capital Management Buys $25.3 Million in Janux Therapeutics Stock